Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
about
Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer TherapyHarnessing the apoptotic programs in cancer stem-like cellsRole of nanotechnology and gene delivery systems in TRAIL-based therapiesMicroRNA-223 Increases the Sensitivity of Triple-Negative Breast Cancer Stem Cells to TRAIL-Induced Apoptosis by Targeting HAX-1Apoptotic death of cancer stem cells for cancer therapy.Tumor associated macrophage × cancer cell hybrids may acquire cancer stem cell properties in breast cancerMammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherin.Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner.Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL.The role of cancer stem cells in breast cancer initiation and progression: potential cancer stem cell-directed therapies.Cancer stem cells and chemoresistance: The smartest survives the raidDifferential expression of genes associated with the progression of renal disease in the kidneys of liver-specific glucokinase gene knockout mice.Breast cancer stem cells.Resistance to Cell Death and Its Modulation in Cancer Stem Cells.Breast cancer proteome takes more than two to tango on TRAIL: beat them at their own game.Cancer stem cells: perspectives for therapeutic targeting.Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells.Knockdown of miR-27a sensitizes colorectal cancer stem cells to TRAIL by promoting the formation of Apaf-1-caspase-9 complex.Erratum to: Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.The plant alkaloid and anti-leukemia drug homoharringtonine sensitizes resistant human colorectal carcinoma cells to TRAIL-induced apoptosis via multiple mechanisms.An unconventional TRAIL to cancer therapy.Fucoxanthin and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Synergistically Promotes Apoptosis of Human Cervical Cancer Cells by Targeting PI3K/Akt/NF-κB Signaling Pathway.Novel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma.Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.The TRAIL system is over-expressed in breast cancer and FLIP a marker of good prognosis.Comparative Study of Multicellular Tumor Spheroid Formation Methods and Implications for Drug Screening.Developing TRAIL/TRAIL death receptor-based cancer therapies.Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised TumourSTAT3 exacerbates survival of cancer stem-like tumorspheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening
P2860
Q26740207-E839808C-9AC4-4DCE-A19F-BD8A2C5EB8C5Q26801037-796489A6-C507-40E1-851E-ED7982E1C048Q28076798-233D92AB-3FD6-4186-B674-2C14CFF19AF7Q28554012-7DA4DBFD-3EC8-424D-8C59-23D246EDC3B1Q33755766-B5AD9FBA-E929-4725-90A8-75F8C94C35FBQ34359276-AB94879F-0131-4FC6-9D7F-7C8D2D9CE12AQ35017138-4D442225-AE61-43BE-B47C-80363FDBCC55Q35957393-B357A307-8615-4C15-87FC-34AA2B2C268DQ36370570-30F7612C-4946-4936-96D0-BEDEE2545DE8Q36405638-FB3A95B8-BC74-4592-8999-06BC8140EECEQ36730432-6DBFB19E-FD69-48B2-A45E-DEC141490C2AQ36790432-05F44843-D9F8-4F2F-9CC3-D027738BA792Q37121784-E1AAB166-3294-4F1F-BC61-9369937D6353Q37708637-E6F0BDBA-1A93-463E-9509-E669B11D4931Q38035209-6E88B002-3746-4A2E-A901-5C345EADCFE3Q38238005-C7686179-5DE6-4BEE-B97F-F0504BAAABA6Q40267794-C8447D79-BA4C-4458-8EEA-39AA76E7DCBEQ41233246-BF1B15E7-CF7F-4964-8534-1FA0632555CAQ42344778-F8BC761A-787C-49E9-B4E5-00888E299AB2Q43468001-B4571AFA-0F82-4940-8EFA-9F9B5C918B5EQ44541139-02FD2D22-929B-435C-B244-763E549FC5C8Q47240787-18E881EC-3492-458B-A31F-AD28F85F17D2Q48531636-A584A3E8-3104-45F0-968E-24BAE8E14775Q48832407-6EA23E57-4B19-4F11-9426-1457D8B67C39Q50449454-196B3D37-AB6D-4A78-B286-BCE600D49917Q52359651-E07573C4-6324-4A97-A667-9DE22AC11495Q53701901-3F20EDAC-3E3E-41D1-A6E1-C119B59C3F22Q57174410-7AE4567B-3A79-4283-8D91-7824B3BA12B4Q58803100-CEFE9D3E-DC1F-4D75-842C-3EF107A70816
P2860
Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Suppression of apoptosis inhib ...... the anti-cancer agent, TRAIL.
@ast
Suppression of apoptosis inhib ...... the anti-cancer agent, TRAIL.
@en
Suppression of apoptosis inhib ...... the anti-cancer agent, TRAIL.
@nl
type
label
Suppression of apoptosis inhib ...... the anti-cancer agent, TRAIL.
@ast
Suppression of apoptosis inhib ...... the anti-cancer agent, TRAIL.
@en
Suppression of apoptosis inhib ...... the anti-cancer agent, TRAIL.
@nl
prefLabel
Suppression of apoptosis inhib ...... the anti-cancer agent, TRAIL.
@ast
Suppression of apoptosis inhib ...... the anti-cancer agent, TRAIL.
@en
Suppression of apoptosis inhib ...... the anti-cancer agent, TRAIL.
@nl
P2093
P2860
P50
P356
P1476
Suppression of apoptosis inhib ...... the anti-cancer agent, TRAIL.
@en
P2093
Luke Piggott
Nader Omidvar
Rhiannon French
P2860
P2888
P356
10.1186/BCR2945
P577
2011-09-14T00:00:00Z
P5875
P6179
1030462236